Skip to content

Effect of heparin on cardiopulmonary resuscitation

Assessment of the effect of heparin on the outcome of CPR: a clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240527061913N1
Enrollment
70
Registered
2024-06-17
Start date
2024-06-20
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiopulmonary resuscitation.

Interventions

Intervention 1: Intervention group: The group who receive heparin at the beginning of CPR. Intervention 2: Control group: The group who receive placebo at the beginning of CPR.

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Be alive at the entrance to emergency department Cardiac arrest occurs in the emergency department The age between 30 to 60 years.

Exclusion criteria

Exclusion criteria: Traumatic patients Has history of previous CPR Asystole be as the first rhythm seen during CPR Receive any anticoagulant during last 12 hours Has any contraindication for heparin injection (such as disturbed coagulation studies, life threatening bleeding, suspicion of ICH) Suspicion of pulmonary embolism or myocardial infarction as the cause of death

Design outcomes

Primary

MeasureTime frame
Level of contiousnes. Timepoint: 72 hours later. Method of measurement: Glasgow Coma scale.

Secondary

MeasureTime frame
Return of spontaneous circulation. Timepoint: 60 minutes. Method of measurement: Examination of physician.;Discharge from the hospital. Timepoint: 30 days later. Method of measurement: Registries of hospital.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSadegh Ebrahimi

Mashhad University of Medical Sciences

Bbrahimisd@mums.ac.ir+98 51 3858 4673

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026